- Report
- January 2026
- 198 Pages
Global
From €3121EUR$3,545USD£2,697GBP
€3468EUR$3,939USD£2,997GBP
- Report
- February 2026
- 250 Pages
Global
From €3953EUR$4,490USD£3,416GBP
- Report
- May 2026
- 174 Pages
Global
From €5150EUR$5,850USD£4,451GBP
- Report
- November 2025
- 182 Pages
Global
From €3962EUR$4,500USD£3,424GBP
- Report
- June 2025
- 209 Pages
Global
From €2201EUR$2,500USD£1,902GBP
- Report
- November 2025
- 150 Pages
Global
From €4270EUR$4,850USD£3,690GBP
- Report
- September 2025
- 150 Pages
Global
From €4270EUR$4,850USD£3,690GBP
- Report
- October 2025
- 160 Pages
Global
From €2956EUR$3,358USD£2,555GBP
€3477EUR$3,950USD£3,005GBP
- Report
- February 2026
- 170 Pages
United States
From €4270EUR$4,850USD£3,690GBP
- Report
- September 2025
- 242 Pages
Global
From €2640EUR$2,999USD£2,282GBP
- Report
- August 2025
- 185 Pages
Global
From €3121EUR$3,545USD£2,697GBP
€3468EUR$3,939USD£2,997GBP
- Report
- February 2026
- 250 Pages
Global
From €3953EUR$4,490USD£3,416GBP
- Report
- May 2026
- 380 Pages
Global
From €5150EUR$5,850USD£4,451GBP
- Report
- November 2025
- 183 Pages
Global
From €3962EUR$4,500USD£3,424GBP
- Report
- June 2025
- 150 Pages
Global
From €2376EUR$2,699USD£2,054GBP
- Report
- May 2025
- 250 Pages
Global
From €4397EUR$4,995USD£3,801GBP
- Report
- August 2025
- 200 Pages
United States
From €2192EUR$2,490USD£1,895GBP
- Report
- December 2025
- 280 Pages
Global
From €4225EUR$4,799USD£3,651GBP
- Report
- January 2026
- 196 Pages
Global
From €3121EUR$3,545USD£2,697GBP
€3468EUR$3,939USD£2,997GBP
- Report
- August 2025
- 184 Pages
Global
From €3121EUR$3,545USD£2,697GBP
€3468EUR$3,939USD£2,997GBP

The Antidepressant market is a subset of the Mental Disorders Drugs market, which includes medications used to treat mental health conditions such as depression, anxiety, bipolar disorder, and schizophrenia. Antidepressants are the most commonly prescribed medications for treating depression, and are typically divided into two categories: selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs). These medications work by increasing the levels of serotonin and norepinephrine in the brain, which can help to improve mood and reduce symptoms of depression.
Some of the major companies in the Antidepressant market include Eli Lilly, Pfizer, GlaxoSmithKline, AstraZeneca, and Bristol-Myers Squibb. These companies produce a variety of antidepressants, including SSRIs and SNRIs, as well as other medications used to treat mental health conditions. Show Less Read more